FASLG and systemic lupus erythematosus: Finally, aPL may also be detected in connective-tissue diseases (CTD), particularly in systemic lupus erythematosus (SLE) patients, where they can be detected in up to 45%, leading to increased subclinical atherosclerosis and chronic damage [5,6].